Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free
  1. Home
  2. Programs
  3. Diabetes Discourse

Antipsychotics and Metabolic Syndrome

ReachMD Healthcare Image
Restart
Resume
Choose a format
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Details
Presenters
Comments
  • Overview

    Antipsychotic medications have dramatically increased in prescriptions, including additional FDA-approved usages for bipolar and depression as well as off-label use. Side effects of these drugs, such as abdominal weight gain, lipid and blood pressure changes, and elevations in fasting glucose, may contribute to metabolic syndrome.  What are the impacts of increased use of antipsychotic medications on diabetes? Join host Dr. Steven Edelman and his guest, associate professor of psychiatry at Harvard Medical School, Dr. David Henderson, as they discuss the need for healthcare providers to be proactive: understanding the patient's risk factors, medical history and the risk-benefit ratio in order to treat effectively.

Recommended
Details
Presenters
Comments
  • Overview

    Antipsychotic medications have dramatically increased in prescriptions, including additional FDA-approved usages for bipolar and depression as well as off-label use. Side effects of these drugs, such as abdominal weight gain, lipid and blood pressure changes, and elevations in fasting glucose, may contribute to metabolic syndrome.  What are the impacts of increased use of antipsychotic medications on diabetes? Join host Dr. Steven Edelman and his guest, associate professor of psychiatry at Harvard Medical School, Dr. David Henderson, as they discuss the need for healthcare providers to be proactive: understanding the patient's risk factors, medical history and the risk-benefit ratio in order to treat effectively.

Schedule14 Dec 2024